| Main Subject |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Productivity > Regain Control Of The Paper Pile-Up |
|
Main Subject - Regain Control Of The Paper Pile-Up
Are you overwhelmed by piles of paper? Does it seem impossible to catch up? Well, it does require some effort on your part an According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product d some paper management skills, but it can be done. Paper causes anxiety because it is often a reminder of all of the things w ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in have to do. An effective paper management system can help move those piles of paper from ‘to-do’ to ‘done!’ First, designate lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. an in-box for all incoming paper and process it frequently. Designate containers for each of the following paper decisions: D here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe it now, Do it later, Delegate it, Toss it, or File it. Do it now- Actually, I recommend processing all of the paper in your i d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro n-box prior to acting on it, at least initially. If not, you may decide to keep acting on each paper and never get around to c ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc mpletely processing your in-box. Do it later- Determine what the actual next step is and then schedule a time and day to do it easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi . Your initial determination might be that you have to respond to an invitation- but later you realize that you have to check nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically ith your co-worker or significant other prior to responding. Most importantly, later never comes. It is essential to block ou and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ t time in your day to actually do it. Delegate it- Many times it is more productive to delegate some tasks than to try to do t ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi em ourselves, even when we have to pay an expert for their time. It may take you two or three times as long to accomplish the ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a same task and often cost the same or less. Experts have the tools and skills to get it done efficiently and effectively. Toss dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod it- Insert ‘recycle’ or ‘shred’ here. Anything with your name and identifying information on it should be shredded and most ot cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin her papers can be recycled. If you have a ‘to shred’ pile that never gets shredded, perhaps it’s time to invest in a better sh tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen edder or delegate this task. File it- I have found the most effective method for filing papers is by their shelf life. A ‘to- t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel do’ may only have a shelf life of one week, whereas insurance policies usually have a shelf life of one year, while tax papers ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust an have a shelf life of ten years. So divide your filing into sections for active, reference, and archive. Active papers shou y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products ld be stored in your ‘prime real estate’ on your desktop. Reference documents can be located in desk filing cabinets or close . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de y. And finally, archive papers should be stored in another location. Designating an in-box and understanding the decisions to elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip be made when processing paper is just the beginning of tackling your paper clutter...but it is your first step towards success tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Call Yield Management Within The Hotel Industry What to Expect From a Top Flight Trade Show Exhibit Company
|